Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 2601 |
Weiss Asset Management
Boston,
Massachusetts
| $0 | -$35 | 0 | – | Closed |
|
| 2602 |
WCF
West Coast Financial
Santa Barbara,
California
| $0 | -$344K | 0 | – | Closed |
|
| 2603 |
WPA
West Paces Advisors
Atlanta,
Georgia
| $0 | -$24.2K | 0 | – | Closed |
|
| 2604 |
WA
Wilshire Advisors
Santa Monica,
California
| $0 | -$13.2K | 0 | – | Closed |
|
| 2605 |
WCM
Winthrop Capital Management
Carmel,
Indiana
| $0 | $0 | 1 | 0% | Maintained |
|
| 2606 |
WorldQuant Millennium Advisors
New York
| $0 | -$3.28M | 0 | – | Closed |
|
| 2607 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
| $0 | -$372K | 0 | – | Closed |
|
| 2608 |
XC
XY Capital
Central,
Hong Kong
| $0 | -$346K | 0 | – | Closed |
|
| 2609 |
YC
Yarbrough Capital
Franklin,
Tennessee
| $0 | -$130K | 0 | – | Closed |
|
| 2610 |
ZIG
Zullo Investment Group
Scranton,
Pennsylvania
| $0 | -$11.1K | 0 | – | Closed |
|